| Company Name: |
ChemShuttle, Inc. |
| Tel: |
0510-83588313-811 18800520310 |
| Email: |
sales@chemshuttle.com |
|
| | L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- Basic information |
| Product Name: | L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- | | Synonyms: | PROTACs Related Compound 4;(S,R,S)-AHPC-C8-NH2 (VH032-C8-NH2);(S,R,S)-AHPC-C8-NH2;(2S,4R)-1-((S)-2-(9-aminononanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide;VH032-C8-NH2;VH032-C7-NH2;L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-;(2S,4R)-1-((S)-2-(9-Aminononanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide , (S,R,S)-AHPC-C8-NH2 | | CAS: | 2341796-79-8 | | MF: | C31H47N5O4S | | MW: | 585.8 | | EINECS: | | | Product Categories: | | | Mol File: | 2341796-79-8.mol | ![L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- Structure](CAS/20240320/GIF/2341796-79-8.gif) |
| | L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- Chemical Properties |
| Boiling point | 844.3±65.0 °C(Predicted) | | density | 1.177±0.06 g/cm3(Predicted) | | form | Solid | | pka | 14.08±0.40(Predicted) | | color | Light yellow to yellow |
| | L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- Usage And Synthesis |
| Uses | (S,R,S)-AHPC-C8-NH2 (VH032-C8-NH2) is a synthesizedE3 ligase ligand-linker conjugatethat incorporates the VH032 based VHL ligand and a linker used for AKT PROTAC degrader. (S,R,S)-AHPC-C8-NH2 is XF038-164A, example 8, extracted from patent WO2019173516A1[1]. | | IC 50 | VHL | | References | [1] Jian Jin, et al. Serine threonine kinase (akt) degradation / disruption compounds and methods of use. Patent WO2019173516A1. |
| | L-Prolinamide, N-(9-amino-1-oxononyl)-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)- Preparation Products And Raw materials |
|